{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:39:19Z","timestamp":1780547959114,"version":"3.54.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Upper tract urothelial carcinoma (UTUC) is a rare and highly malignant urothelial tumor originating from the renal pelvis and ureter associated with poor prognosis. It has been established that 70% of ureteral tumors occur in the lower ureter. Radical nephroureterectomy (RNU) with ipsilateral bladder cuff excision is regarded as the standard treatment for UTUC. Current evidence supports the role of lymph node dissection (LND) in determining tumor staging, but no consensus has been reached on the potential survival benefits. The present study retrospectively analyzed cases of UTUC limited to the lower ureter to evaluate the survival benefits of LND during RNU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present study retrospectively analyzed data from patients with UTUC limited to the lower ureter from two medical centers from 2000 to 2016 and assessed the survival outcomes, including recurrence-free survival (RFS) and cancer specific survival (CSS). During subgroup analysis, we stratified by pathological tumor (pT) stages and postoperative adjuvant chemotherapy (AC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study cohort included 297 patients separated into LND (n=111) and non-LND (n=186) groups. The two groups were comparable except for the pathological N stage. The LND group was associated with superior survival in terms of RFS (27.0% vs. 18.3%, p=0.044) and CSS (53.2 vs. 39.8%, p=0.031) compared to the non-LND group (n=186). In pT2-4 patients, the LND group was associated with better 3-year RFS (50.5% vs. 32.3%, p&amp;lt;0.05), 5-year RFS (29.7% vs. 12.0%, p&amp;lt;0.05), and overall RFS (18.7% vs. 6.0%, p&amp;lt;0.05) than the non-LND group. Besides, the LND group was associated with a significantly better 3-year CSS (68.1% vs. 49.6%, p=0.003), 5-year CSS (51.6% vs. 30.8%, p&amp;lt;0.05) and overall CSS (45.1% vs. 24.1%, p&amp;lt;0.05). In patients that underwent AC, the LND group had better survival benefits in terms of RFS (29.4 vs. 16.7%, p=0.023) and CSS (52.9% vs. 40.5%, p=0.038) compared to the non-LND group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LND has survival benefits in patients with UTUC localized to the lower ureter, especially for\u2265pT<jats:sub>2<\/jats:sub> stage UTUC and AC cohorts. Overall, the therapeutic effect of LND in UTUC cannot be replaced by AC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1115830","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:54:46Z","timestamp":1681448086000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Benefits of lymphadenectomy for upper tract urothelial carcinoma only located in the lower ureter: a bicentre retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yupeng","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of urology guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09675.x","article-title":"Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005","volume":"107","author":"Raman","year":"2011","journal-title":"BJU Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)38730-x","article-title":"Carcinoma of the ureter: A clinicopathologic study of 49 cases","volume":"142","author":"Anderstr\u00f6m","year":"1989","journal-title":"J Urol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-014-1311-8","article-title":"Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"33","author":"Hurel","year":"2015","journal-title":"World J Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000499240","article-title":"Tumor location based segmentation in upper-tract urothelial carcinoma impacts on the urothelial recurrence-free survival: A multi-institutional database study","volume":"14","author":"Inamoto","year":"2020","journal-title":"Curr Urol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11474.x","article-title":"Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: Results from the Canadian upper tract collaboration","volume":"112","author":"Fairey","year":"2013","journal-title":"BJU Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.02.021","article-title":"Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"181","author":"Roscigno","year":"2009","journal-title":"J Urol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.009","article-title":"Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer","volume":"60","author":"Roscigno","year":"2011","journal-title":"Eur Urol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2019.11.29","article-title":"The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma","volume":"9","author":"Goltzman","year":"2020","journal-title":"Transl Androl Urol."},{"key":"B12","article-title":"Urothelial carcinoma of the upper urinary tract","volume-title":"EAU- ESTRO-ESUR-SIOG guidelines, 2017 edn","author":"Roupret","year":"2017"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.09.008","article-title":"The effect of surgical approach on performance of lymphadenectomy and perioperative morbidity for radical nephroureterectomy","volume":"34","author":"Pearce","year":"2016","journal-title":"Urol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30516","article-title":"Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract","volume":"123","author":"Zareba","year":"2017","journal-title":"Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/2090598X.2020.1791563","article-title":"Lymph node dissection for upper urothelial tract carcinoma: A systematic review","volume":"19","author":"Chan","year":"2021","journal-title":"Arab J Urol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyaa256","article-title":"Therapeutic benefit of lymphadenectomy for older patients with urothelial carcinoma of the upper urinary tract: A propensity score matching study","volume":"51","author":"Ishiyama","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.09.015","article-title":"Potential benefit of lymph node dissection during radical nephroureterectomy for upper tract urothelial carcinoma: A systematic review by the European association of urology guidelines panel on non-muscle-invasive bladder cancer","volume":"5","author":"Dominguez-Escrig","year":"2019","journal-title":"Eur Urol Focus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1356-6","article-title":"Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population -based, propensity score-matched study","volume":"24","author":"Dong","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2017.04.004","article-title":"Effect of lymphadenectomy during radical nephroureterectomy in locally advanced upper tract urothelial carcinoma","volume":"15","author":"Ikeda","year":"2017","journal-title":"Clin Genitourin Canc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"409.e9","DOI":"10.1016\/j.urolonc.2022.04.015","article-title":"Benefit of lymph node dissection in cN+ patients in the treatment of upper tract urothelial carcinoma: Analysis of NCDB registry","volume":"40","author":"Piontkowski","year":"2022","journal-title":"Urol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1115830\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:54:48Z","timestamp":1681448088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1115830\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":20,"alternative-id":["10.3389\/fonc.2023.1115830"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1115830","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"article-number":"1115830"}}